Werfen North America

🎉 Happy New Year! 🎉 May 2025 bring you joy, success, and countless moments to cherish. Here's to new beginnings, fresh starts, and for all of us at Werfen, powering patient care! #HappyNewYear #Welcome2025

Werfen was a proud sponsor of the Massachusetts Women’s Conference and filled with even more pride watching our Chief Medical Officer, Dr. Annie Winkler present on the realities of managing career demands and the elusive concept of work-life balance. Thank you to the Conferences for Women for bringing together such inspiring speakers and offering a space for professional women to learn and grow within the Greater Boston community. #MassWomen

Have you visited Werfen Academy recently? We have a new PACE self-study course available on anti-HMGCR autoantibodies in myositis.  The new course, The Role of Anti-HMGCR Autoantibodies in Myositis: • Defines the important role of autoantibodies in idiopathic inflammatory myopathies (myositis) • Outlines the salient histologic and clinical features of anti HMGCR myopathy • Examines the role of HMGCR autoantibodies in myositis Log in or register today to see our latest #Autoimmunity self-study course.   https://hubs.ly/Q02ZyQvp0 #Autoimmunity #Autoantibodies #Myositis #HMGCR #PACECredit

Today, our Chairman Marc Rubiralta Giralt, together with Werfen senior leaders, and the Town Manager of Bedford, MA, Matthew J. Hanson, cut the ribbon on a new building at our Hemostasis and Acute Care Diagnostics Technology Center in Bedford.   The $50 million state-of-art building includes sustainable features and adds 105,000 sq. ft. (nearly 9,800 m2), providing ample space to grow our team and innovate in Specialized Diagnostics. The employee base there has grown to over 1,200, with the new building accommodating up to 2,000 employees, who will support innovation for years to come.   We look forward to Powering Patient Care at the new building!   A special thanks to Giovanni Russi, Mark Olsen, Brian Reiss, and everyone who attended the celebration.

Last chance to register for tomorrow's virtual event, Navigating Bleeding Management Guidelines from Global Regions: Practical Insights and Applications. Our speakers will discuss the value of viscoelastic testing (VET) for bleeding management, provide an overview of regional guidelines and underlying evidence, and share how VET has impacted their patient management. Register now! https://hubs.ly/Q02X4VYk0

Join us in raising awareness for Crohn's and Colitis Week! Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel diseases (IBD), are chronic conditions causing inflammation in the digestive tract. These diseases can lead to symptoms like severe abdominal pain, diarrhea, fatigue, and even life-threatening complications. Let's unite to support those living with these challenging conditions, spread understanding, and empower each other with knowledge about managing symptoms and seeking effective treatment. #CrohnsAndColitisWeek #Autoimmunity #PoweringPatientCare

This Thanksgiving season, we're grateful for the lifesaving work of our partners in transfusion testing and the incredible difference they make for patients and donors every day. 💙 At Werfen, we believe in not just supporting your efforts but also actively giving back. That’s why we’re proud to participate in the #WeGiveBlood Drive, ensuring even more lives are impacted through donation. 📸 Meet Darlene Sanders, a Blood Bank Technical Specialist in the Great Lakes Region leading by example and rolling up their sleeve to donate. Together, we’re honoring the spirit of giving—both in and out of the lab. Let’s make a difference together. If you’re inspired to join, find a donation center near you and help save lives this holiday season. 🩸 #WerfenCares #GratitudeInAction #WeGiveBlood Would you consider donating blood this season? Share your story in the comments! 👇

Werfen’s GEM Premier 7000 with iQM3*—the first, point-of-care blood gas testing system with integrated hemolysis detection—has been honored with four prestigious awards; including three Excellence Awards, recognizing the most notable medical device advancements, and the 2024 R&D 100 Award, recognizing the technological significance of new products worldwide. Discover what makes this system a breakthrough in blood gas testing: https://hubs.ly/Q02Z5q5l0 #MedicalExcellence #HealthcareInnovation *Not available in all countries.

There is still time to register for this virtual event, Navigating Bleeding Management Guidelines from Global Regions: Practical Insights and Applications. Our speakers will discuss the value of viscoelastic testing (VET) for bleeding management, provide an overview of regional guidelines and underlying evidence, and share how VET has impacted their patient management. Register now! https://hubs.ly/Q02X4XGF0

Watch MLO's in-booth highlights of our new GEM® Premier™ 7000 with iQM®3* introduction at the Annual ADLM meeting. Watch now!https://hubs.ly/Q02X147r0 *Not Health Canada licensed. Not available in all countries.